好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Demographic factors associated with unplanned healthcare resource utilization (HRU) among people with epilepsy (PWE)
Health Care Disparities
P6 - Poster Session 6 (5:30 PM-6:30 PM)
4-005

To identify demographic variables associated with unplanned HRU in PWE.

Epilepsy is a common, chronic disease with a recognized high HRU. There is increased urgency to document, assess barriers, and reduce racial and economic disparities in care. Sparse data exists on short index time HRU.

We performed a retrospective cohort analysis of PWE compared with patients without epilepsy seen at 18 outpatient neurology clinics within an academic health system between June 2018 and August 2022. Among PWE, we assessed associations between demographic variables and HRU data at specific time points between HRU events and index neurology clinic visits using a logit model. Demographic data was combined with Health Plan claims HRU data in 4 domains (Mortality all causes, Hospitalization all causes, Emergency Department (ED) treat and release all causes and Urgent care all causes) at 7, 30 and 90-days from an index neurology clinic visit.

The epilepsy cohort included 6485 unique patients (13159 encounters; 53.1% females, 10.1% black, median age 46.4 years). The epilepsy cohort showed significantly more hospitalizations, ED visits, and urgent care visits at all time-points compared to the general neurology cohort (N=53422) (p<0.05). Within the epilepsy cohort: Male gender and Black race correlated with increased ED visits at all time-points; 2) age 65 and older (N=1602) with increased 90-day Mortality and 30 and 90-day Hospitalizations and decreased 7 and 30-day ED visits; 3) Patients within the highest 25th quartile of the area deprivation index (ADI) (N=2958 patients; 16.3 % black) showed increased 30 and 90-day ED visits (p<0.05).

Specific demographics among PWE are associated with unplanned HRU within the 4 domains assessed for PWE with a short index time from neurology outpatient visits. The observed differences may guide development of targeted tools for timely care interventions.

Authors/Disclosures
Alexandra Urban, MD, FAAN (University of Pittsburgh School of Medicine)
PRESENTER
Dr. Urban has received personal compensation in the range of $0-$499 for serving as a Consultant for Neuropace. Dr. Urban has received personal compensation in the range of $0-$499 for serving as a Consultant for LivaNova.
Laura A. Kirkpatrick, MD (UPMC Children's Hospital of Pittsburgh) The institution of Dr. Kirkpatrick has received research support from American Epilepsy Society. The institution of Dr. Kirkpatrick has received research support from Child Neurologist Career Development Program. The institution of Dr. Kirkpatrick has received research support from Child Neurology Foundation. The institution of Dr. Kirkpatrick has received research support from Rosenau Family Research Foundation. The institution of Dr. Kirkpatrick has received research support from Society of Family Planning. The institution of Dr. Kirkpatrick has received research support from Pediatric Epilepsy Research Consortium. Dr. Kirkpatrick has received personal compensation in the range of $500-$4,999 for serving as a Meeting Attendee with One8 Foundation. Dr. Kirkpatrick has received personal compensation in the range of $500-$4,999 for serving as a Meeting Attendee with Brigham and Women's Hospital. Dr. Kirkpatrick has received personal compensation in the range of $0-$499 for serving as a Meeting Attendee with Pediatric Epilepsy Research Consortium. Dr. Kirkpatrick has received personal compensation in the range of $0-$499 for serving as a Grant reviewer with Society of Family Planning. Dr. Kirkpatrick has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Norton Children's Hospital. Dr. Kirkpatrick has a non-compensated relationship as a Board of Directors member with My Epilepsy Story that is relevant to AAN interests or activities.
Vijayalakshmi Rajasekaran, MD, FAAN (University of Pittsburgh) The institution of Dr. Rajasekaran has received research support from UCB Pharmaceutical drug trail . The institution of Dr. Rajasekaran has received research support from Xenon and Biohaven. Dr. Rajasekaran has received personal compensation in the range of $0-$499 for serving as a Consultant with NaoX.
Joanna S. Fong-Isariyawongse, MD, FAAN (UPMC) Dr. Fong-Isariyawongse has nothing to disclose.
Anto Bagic, MD, PhD (UPMC/Univesrity of Pittsburgh) Dr. Bagic has nothing to disclose.
Parthasarathy Thirumala, MD, FAAN (University of Pittsburgh Medical Center) The institution of Dr. Thirumala has received research support from University of Pittsburgh.